Literature DB >> 32302483

Pyrocinchonimides Conjugate to Amine Groups on Proteins via Imide Transfer.

Mark B Richardson1, Kristin N Gabriel2, Joseph A Garcia1, Shareen N Ashby1, Rebekah P Dyer2, Joshua K Kim2, Calvin J Lau3, John Hong4, Ryan J Le Tourneau1, Sanjana Sen2, David L Narel2, Benjamin B Katz1, Joseph W Ziller1, Sudipta Majumdar1, Philip G Collins3, Gregory A Weiss1,2.   

Abstract

Advances in bioconjugation, the ability to link biomolecules to each other, small molecules, surfaces, and more, can spur the development of advanced materials and therapeutics. We have discovered that pyrocinchonimide, the dimethylated analogue of maleimide, undergoes a surprising transformation with biomolecules. The reaction targets amines and involves an imide transfer, which has not been previously reported for bioconjugation purposes. Despite their similarity to maleimides, pyrocinchonimides do not react with free thiols. Though both lysine residues and the N-termini of proteins can receive the transferred imide, the reaction also exhibits a marked preference for certain amines that cannot solely be ascribed to solvent accessibility. This property is peculiar among amine-targeting reactions and can reduce combinatorial diversity when many available reactive amines are available, such as in the formation of antibody-drug conjugates. Unlike amides, the modification undergoes very slow reversion under high pH conditions. The reaction offers a thermodynamically controlled route to single or multiple modifications of proteins for a wide range of applications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32302483      PMCID: PMC7337330          DOI: 10.1021/acs.bioconjchem.0c00143

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  77 in total

1.  Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation.

Authors:  Calise Bahou; Richard J Spears; Abil E Aliev; Antoine Maruani; Marcos Fernandez; Faiza Javaid; Peter A Szijj; James R Baker; Vijay Chudasama
Journal:  Chem Commun (Camb)       Date:  2019-12-05       Impact factor: 6.222

Review 2.  Analytical methods for physicochemical characterization of antibody drug conjugates.

Authors:  Aditya Wakankar; Yan Chen; Yatin Gokarn; Fredric S Jacobson
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

Review 3.  Minireview: Addressing the retro-Michael instability of maleimide bioconjugates.

Authors:  Peter A Szijj; Calise Bahou; Vijay Chudasama
Journal:  Drug Discov Today Technol       Date:  2018-07-29

Review 4.  Antibody therapy of cancer.

Authors:  Andrew M Scott; Jedd D Wolchok; Lloyd J Old
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

5.  Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum.

Authors:  A L Tarentino; T H Plummer
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 6.  Residue-Specific Peptide Modification: A Chemist's Guide.

Authors:  Justine N deGruyter; Lara R Malins; Phil S Baran
Journal:  Biochemistry       Date:  2017-07-17       Impact factor: 3.162

7.  Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug Conjugates.

Authors:  Dobeen Hwang; Kohei Tsuji; HaJeung Park; Terrence R Burke; Christoph Rader
Journal:  Bioconjug Chem       Date:  2019-11-01       Impact factor: 4.774

8.  Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma.

Authors:  Cong Wei; Guodong Zhang; Tracey Clark; Frank Barletta; L Nathan Tumey; Brian Rago; Steven Hansel; Xiaogang Han
Journal:  Anal Chem       Date:  2016-04-21       Impact factor: 6.986

9.  Homogeneous bispecifics by disulfide bridging.

Authors:  Elizabeth A Hull; Maria Livanos; Enrique Miranda; Mark E B Smith; Kerry A Chester; James R Baker
Journal:  Bioconjug Chem       Date:  2014-08-01       Impact factor: 4.774

10.  Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging.

Authors:  Felix F Schumacher; João P M Nunes; Antoine Maruani; Vijay Chudasama; Mark E B Smith; Kerry A Chester; James R Baker; Stephen Caddick
Journal:  Org Biomol Chem       Date:  2014-10-07       Impact factor: 3.876

View more
  2 in total

1.  Dichloro Butenediamides as Irreversible Site-Selective Protein Conjugation Reagent.

Authors:  Victor Laserna; Daniel Abegg; Cláudia F Afonso; Esther M Martin; Alexander Adibekian; Peter Ravn; Francisco Corzana; Gonçalo J L Bernardes
Journal:  Angew Chem Int Ed Engl       Date:  2021-09-29       Impact factor: 15.336

2.  Single-molecule Taq DNA polymerase dynamics.

Authors:  Mackenzie W Turvey; Kristin N Gabriel; Wonbae Lee; Jeffrey J Taulbee; Joshua K Kim; Silu Chen; Calvin J Lau; Rebecca E Kattan; Jenifer T Pham; Sudipta Majumdar; Davil Garcia; Gregory A Weiss; Philip G Collins
Journal:  Sci Adv       Date:  2022-03-11       Impact factor: 14.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.